A particular study [40] conducted on non-small cell lung cancer (NSCLC) patients observed a notable upregulation of PD-1/PD-L1 expression alongside a downregulation of MHC-I expression within the tumor tissues. The gene discussed is PDCD1; the disease is neoplasm.